UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
HealthStream
HSTM
$842M
| $1.52M | ﹤0.01% |
54,440
+10,699
| +24% | +$285K |
|
4027
CALL
New Oriental
EDU
$8.84B
| $1.52M | ﹤0.01% |
19,521
+9,521
| +95% | +$776K |
|
4028
Strive Emerging Markets ex-China ETF
STXE
$139M
| $1.52M | ﹤0.01% |
50,964
+919
| +2% | +$26.4K |
|
|
SAGE
4029
DELISTED
Sage Therapeutics
SAGE
| $1.52M | ﹤0.01% |
139,563
-115,663
| -45% | -$1.48M |
|
4030
Alpha Metallurgical Resources
AMR
$1.95B
| $1.51M | ﹤0.01% |
5,398
-5,164
| -49% | -$1.6M |
|
4031
Arcturus Therapeutics
ARCT
$210M
| $1.51M | ﹤0.01% |
62,159
-45,780
| -42% | -$1.39M |
|
4032
PUT
Cinemark Holdings
CNK
$4.26B
| $1.51M | ﹤0.01% |
70,000
| – | – |
|
|
GMS
4033
DELISTED
GMS Inc
GMS
| $1.51M | ﹤0.01% |
18,768
-13,504
| -42% | -$1.25M |
|
4034
PUT
Intuitive Surgical
ISRG
$141B
| $1.51M | ﹤0.01% |
3,400
-99,100
| -97% | -$39.5M |
|
4035
OceanFirst Financial
OCFC
$1.86B
| $1.5M | ﹤0.01% |
94,630
-32,549
| -26% | -$492K |
|
4036
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.47B
| $1.5M | ﹤0.01% |
40,961
+33,418
| +443% | +$1.24M |
|
4037
Artesian Resources
ARTNA
$361M
| $1.5M | ﹤0.01% |
42,713
-12,829
| -23% | -$465K |
|
4038
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$336M
| $1.5M | ﹤0.01% |
31,255
-32,194
| -51% | -$1.55M |
|
|
AAN
4039
DELISTED
The Aaron's Company Inc
AAN
| $1.5M | ﹤0.01% |
150,050
+119,194
| +386% | +$932K |
|
4040
Patrick Industries
PATK
$2.81B
| $1.49M | ﹤0.01% |
20,636
-18,624
| -47% | -$1.36M |
|
4041
CALL
Regions Financial
RF
$27B
| $1.49M | ﹤0.01% |
74,500
-3,800
| -5% | -$73.7K |
|
4042
Ameresco
AMRC
$1.37B
| $1.49M | ﹤0.01% |
51,813
+6,363
| +14% | +$175K |
|
4043
CALL
Gold Fields
GFI
$36B
| $1.49M | ﹤0.01% |
100,000
| – | – |
|
|
VRNA
4044
DELISTED
Verona Pharma
VRNA
| $1.49M | ﹤0.01% |
102,879
+101,044
| +5,506% | +$1.48M |
|
|
PARA
4045
CALL
DELISTED
Paramount Global Class B
PARA
| $1.49M | ﹤0.01% |
143,100
-96,900
| -40% | -$1.13M |
|
4046
Lemonade
LMND
$4.09B
| $1.48M | ﹤0.01% |
89,903
-800
| -0.9% | -$13.3K |
|
4047
Takeda Pharmaceutical
TAK
$55.9B
| $1.48M | ﹤0.01% |
114,471
+18,244
| +19% | +$242K |
|
4048
Arrow Financial
AROW
$649M
| $1.48M | ﹤0.01% |
56,842
-10,679
| -16% | -$256K |
|
|
SAVE
4049
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.48M | ﹤0.01% |
404,239
+41,877
| +12% | +$162K |
|
4050
PUT
Teladoc Health
TDOC
$1.24B
| $1.48M | ﹤0.01% |
151,100
| – | – |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.